AI Enables Non-Invasive, Accurate Screening for Down Syndrome in the First Trimester

Down Syndrome, also known as Trisomy 21, is the most common chromosomal abnormality causing developmental delay and intellectual disability and can be identified in utero. Many pregnant women seek to determine whether their fetus has this abnormality.

Now researchers from the Institute of Automation of the Chinese Academy of Sciences (CASIA) have developed an intelligent prediction model to achieve non-invasive screening of Down Syndrome using ultrasound image.

This work was published in JAMA Network Open on June 21.

For decades, ultrasound images have been widely used for screening fetuses with Down Syndrome due to the method's safety, convenience, and low cost. However, using common ultrasound indicators, detection accuracy is less than 80% in actual ultrasound examinations.

Invasive methods such as villus biopsy, amniocentesis, and fetal umbilical venipuncture are also commonly used to detect Down Syndrome.

In this study, the researchers developed a convolutional neural network (CNN) to construct a deep learning (DL) model that could learn representative features from ultrasound images in order to identify fetuses with Down Syndrome.

A CNN is a deep learning algorithm that can take an input image, assign importance (i.e., learnable weights and biases) to various aspects/objects within the image and differentiate one from the other. A CNN can have tens or hundreds of hidden layers. The first layer learns how to detect edges and the last one learns how to detect more complex shapes. This research involved 11 hidden layers.

To further interpret the DL model in a human-readable form, the researchers also used a class activation map (CAM) to shed light on what the model focused on and how it explicitly enabled the CNN to learn discriminative features for risk scores.

The researchers used two-dimensional ultrasound images of the midsagittal plane of the fetal face between 11 and 14 weeks of gestation. Each image was segmented with a bounding box to show only the fetal head. The study comprised a total of 822 cases and controls, with 550 participants in the training set and 272 participants in the validation set.

The researchers found that the first five levels of feature maps visualized by CAM vividly showed the process of learning representative features. The CAM applied to the final layer showed the visualized response regions for the model's decision-making.

"This non-invasive screening model constructed for Down Syndrome in early pregnancy is significantly superior to existing, commonly used manual labeling markers, improving prediction accuracy by more than 15%. It's also superior to the current conventional invasive screening method for Down Syndrome based on maternal serum," said TIAN Jie, corresponding author of the study.

The proposed model is expected to become a non-invasive, inexpensive, and convenient screening tool for Down Syndrome in early pregnancy.

The research is supported by the National Natural Science Foundation of China and the Key R&D Program of the Ministry of Science and Technology.

Zhang L, Dong D, Sun Y, Hu C, Sun C, Wu Q, Tian J.
Development and Validation of a Deep Learning Model to Screen for Trisomy 21 During the First Trimester From Nuchal Ultrasonographic Images.
JAMA Netw Open. 2022 Jun 1;5(6):e2217854. doi: 10.1001/jamanetworkopen.2022.17854

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...